Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Internal Medicine, University of Nebraska Medical Center, College of Medicine, Omaha, Nebraska, USA.
VA Nebraska-Western Iowa Health Systems, Omaha, Nebraska, USA.
Alcohol Clin Exp Res. 2022 Jun;46(6):1023-1035. doi: 10.1111/acer.14838. Epub 2022 May 2.
Coronavirus Disease 2019 (COVID-19) has affected every country globally, with hundreds of millions of people infected with the SARS-CoV-2 virus and over 6 million deaths to date. It is unknown how alcohol use disorder (AUD) affects the severity and mortality of COVID-19. AUD is known to increase the severity and mortality of bacterial pneumonia and the risk of developing acute respiratory distress syndrome. Our objective is to determine whether individuals with AUD have increased severity and mortality from COVID-19.
We utilized a retrospective cohort study of inpatients and outpatients from 44 centers participating in the National COVID Cohort Collaborative. All were adult COVID-19 patients with and without documented AUDs.
We identified 25,583 COVID-19 patients with an AUD and 1,309,445 without. In unadjusted comparisons, those with AUD had higher odds of hospitalization (odds ratio [OR] 2.00, 95% confidence interval [CI] 1.94 to 2.06, p < 0.001). After adjustment for age, sex, race/ethnicity, smoking, body mass index, and comorbidities, individuals with an AUD still had higher odds of requiring hospitalization (adjusted OR [aOR] 1.51, CI 1.46 to 1.56, p < 0.001). In unadjusted comparisons, individuals with AUD had higher odds of all-cause mortality (OR 2.18, CI 2.05 to 2.31, p < 0.001). After adjustment as above, individuals with an AUD still had higher odds of all-cause mortality (aOR 1.55, CI 1.46 to 1.65, p < 0.001).
This work suggests that AUD can increase the severity and mortality of COVID-19 infection. This reinforces the need for clinicians to obtain an accurate alcohol history from patients hospitalized with COVID-19. For this study, our results are limited by an inability to quantify the daily drinking habits of the participants. Studies are needed to determine the mechanisms by which AUD increases the severity and mortality of COVID-19.
2019 年冠状病毒病(COVID-19)已经影响到全球每个国家,数以亿计的人感染了 SARS-CoV-2 病毒,死亡人数已达 600 多万。目前尚不清楚酒精使用障碍(AUD)如何影响 COVID-19 的严重程度和死亡率。众所周知,AUD 会增加细菌性肺炎的严重程度和死亡率,并增加发生急性呼吸窘迫综合征的风险。我们的目的是确定 AUD 是否会使 COVID-19 的严重程度和死亡率增加。
我们利用了来自参与国家 COVID 队列协作的 44 个中心的住院患者和门诊患者的回顾性队列研究。所有患者均为患有和不患有记录在案的 AUD 的成年 COVID-19 患者。
我们确定了 25583 名 COVID-19 伴 AUD 患者和 1309445 名无 AUD 患者。在未调整的比较中,AUD 患者住院的可能性更高(优势比[OR]2.00,95%置信区间[CI]1.94 至 2.06,p<0.001)。在调整年龄、性别、种族/民族、吸烟、体重指数和合并症后,AUD 患者仍有更高的住院需求(调整后的 OR[aOR]1.51,CI 1.46 至 1.56,p<0.001)。在未调整的比较中,AUD 患者全因死亡率的可能性更高(OR 2.18,CI 2.05 至 2.31,p<0.001)。在上述调整后,AUD 患者的全因死亡率仍有更高的可能性(aOR 1.55,CI 1.46 至 1.65,p<0.001)。
这项工作表明,AUD 会增加 COVID-19 感染的严重程度和死亡率。这再次强调了临床医生需要从 COVID-19 住院患者那里获得准确的酒精史。对于这项研究,我们的结果受到无法量化参与者的日常饮酒习惯的限制。需要研究确定 AUD 如何增加 COVID-19 的严重程度和死亡率的机制。